The experimentally demonstrated effects of hyperbaric oxygen therapy on:
make it a useful adjunct in treating problem wounds such as diabetic foot ulcers.
Complications associated with diabetes are the leading cause of non-traumatic lower-extremity amputations. Hyperbaric oxygen therapy, as a medical treatment for diabetic wounds of the extremities, is approved by Medicare and the FDA, and is reimbursed by most private insurance companies.
HBOT has been proven effective in the treatment of diabetic wounds and foot ulcers for several reasons:
Numerous studies have investigated the use of HBOT in the treatment of diabetic wounds and foot ulcers, with promising results. A systematic review published in the journal Diabetes Care found that HBOT was associated with a significantly higher rate of wound healing compared to standard care. In another review of 763 patients across seven studies, amputation rates decreased from 43% in patients who did not receive hyperbarics to 21% in patients who received hyperbaric oxygen therapy.
In addition, a randomized controlled trial published in the Journal of Diabetes and its Complications found that HBOT was effective in reducing the risk of amputation by over 50% in patients with diabetic foot ulcers. In another study published in Diabetes Care, patients who received HBOT had a significantly lower risk of amputation than those who received standard wound care. After one year, only 6.5% of patients who received HBOT had undergone amputation, compared to 24% of patients who received standard wound care.
In another randomized, controlled trial published in the New England Journal of Medicine, patients with diabetic foot ulcers who received HBOT had a significantly higher rate of healing than those who received standard wound care treatments alone. The study found that after 12 weeks, 56% of patients who received HBOT had complete healing of their foot ulcers, compared to only 39% of patients who received standard wound care.
Another study published in the Journal of Wound Care found that HBOT was effective in reducing the size of diabetic foot ulcers. The study included 28 patients with diabetic foot ulcers who received 40 sessions of HBOT. After 40 sessions, the average size of the foot ulcers had decreased by 92%.
Our physician partners have referred thousands of patients with non-healing diabetic foot wounds. Of those patients, over 75% have seen near complete healing, while over 90% have seen a significant decrease in the size of their wounds. Our medical director and nurse practitioners work closely with your care team. Have your office call our practitioners today to discuss how we might help you heal your patients.
Hyperbaric oxygen therapy (HBOT) has been promoted as an effective treatment for diabetic foot wounds, and the first controlled trial for this indication was reported (in Diabetes Care) over 20 years ago. Advocates have suggested that the experimentally demonstrated effects of HBOT on improving wound tissue hypoxia, enhancing perfusion, reducing edema, downregulating inflammatory cytokines, promoting fibroblast proliferation, collagen production, and angiogenesis make it a useful adjunct in clinical practice for “problem wounds,” such as diabetic foot ulcers
Have more Questions?